These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31427302)

  • 1.
    Tanner L; Evans JC; Seldon R; Jordaan A; Warner DF; Haynes RK; Parkinson CJ; Wiesner L
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427302
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel 2-methoxypyridylamino-substituted riminophenazine derivatives as antituberculosis agents.
    Zhang D; Liu Y; Zhang C; Zhang H; Wang B; Xu J; Fu L; Yin D; Cooper CB; Ma Z; Lu Y; Huang H
    Molecules; 2014 Apr; 19(4):4380-94. PubMed ID: 24722591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy.
    Tanner L; Mashabela GT; Omollo CC; de Wet TJ; Parkinson CJ; Warner DF; Haynes RK; Wiesner L
    Microbiol Spectr; 2021 Oct; 9(2):e0043421. PubMed ID: 34585951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation.
    Lu Y; Zheng M; Wang B; Fu L; Zhao W; Li P; Xu J; Zhu H; Jin H; Yin D; Huang H; Upton AM; Ma Z
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5185-93. PubMed ID: 21844321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of Riminophenazines against Mycobacterium tuberculosis: A Review of Studies that Might be Contenders for Use as Antituberculosis Agents.
    Bvumbi MV
    ChemMedChem; 2020 Dec; 15(23):2207-2219. PubMed ID: 32844566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid.
    López-Gavín A; Tudó G; Vergara A; Hurtado JC; Gonzalez-Martín J
    Int J Antimicrob Agents; 2015 Nov; 46(5):582-5. PubMed ID: 26421981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis.
    Xu J; Tasneen R; Peloquin CA; Almeida DV; Li SY; Barnes-Boyle K; Lu Y; Nuermberger E
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis.
    Upton AM; Cho S; Yang TJ; Kim Y; Wang Y; Lu Y; Wang B; Xu J; Mdluli K; Ma Z; Franzblau SG
    Antimicrob Agents Chemother; 2015 Jan; 59(1):136-44. PubMed ID: 25331696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antituberculosis activities of clofazimine and its new analogs B4154 and B4157.
    Reddy VM; Nadadhur G; Daneluzzi D; O'Sullivan JF; Gangadharam PR
    Antimicrob Agents Chemother; 1996 Mar; 40(3):633-36. PubMed ID: 8851584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activities of clofazimine against Mycobacterium tuberculosis in vitro and in vivo].
    Lu Y; Zheng MQ; Wang B; Zhao WJ; Li P; Chu NH; Liang BW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Oct; 31(10):752-5. PubMed ID: 19080601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].
    Lu Y; Wang B; Zhao WJ; Zheng MQ; Li P; Fu L; Liang BW
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Sep; 33(9):675-8. PubMed ID: 21092635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
    Cavanaugh JS; Jou R; Wu MH; Dalton T; Kurbatova E; Ershova J; Cegielski JP;
    J Antimicrob Chemother; 2017 Jun; 72(6):1678-1687. PubMed ID: 28333192
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Xu J; Wang B; Fu L; Zhu H; Guo S; Huang H; Yin D; Zhang Y; Lu Y
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic evaluation of structure-activity relationships of the riminophenazine class and discovery of a C2 pyridylamino series for the treatment of multidrug-resistant tuberculosis.
    Liu B; Liu K; Lu Y; Zhang D; Yang T; Li X; Ma C; Zheng M; Wang B; Zhang G; Wang F; Ma Z; Li C; Huang H; Yin D
    Molecules; 2012 Apr; 17(4):4545-59. PubMed ID: 22510605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169).
    Lupien A; Vocat A; Foo CS; Blattes E; Gillon JY; Makarov V; Cole ST
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Pyrimidines as Antitubercular Agents.
    Inoyama D; Paget SD; Russo R; Kandasamy S; Kumar P; Singleton E; Occi J; Tuckman M; Zimmerman MD; Ho HP; Perryman AL; Dartois V; Connell N; Freundlich JS
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311070
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis.
    van Rensburg CE; Jooné GK; Sirgel FA; Matlola NM; O'Sullivan JF
    Chemotherapy; 2000; 46(1):43-8. PubMed ID: 10601797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo.
    Ammerman NC; Swanson RV; Tapley A; Moodley C; Ngcobo B; Adamson J; Dorasamy A; Moodley S; Mgaga Z; Bester LA; Singh SD; Almeida DV; Grosset JH
    J Antimicrob Chemother; 2017 Feb; 72(2):455-461. PubMed ID: 27798204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
    Rastogi N; Labrousse V; Goh KS
    Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.